Uncategorized

Takeda announced strong financial results for fiscal year 2022, delivering or exceeding management guidance, driven by the performance of its Growth & Launch Products.

Innovent Biologics, Inc. announced that the phase 2 clinical study of higher dose mazdutide in Chinese adults with obesity achieved the 24-week primary endpoint.

POXEL SA announced its participation at the JMP Securities Life Science Conference, to be held in New York, NY, Monday, May 15, and Tuesday, May 16, 2023.

Sensorion a pioneering clinical-stage biotechnology company which specializes in gene therapies in the ear, is pleased to announce its participation in the ASGCT Annual Meeting taking place on May 16-20, 2023, in Los Angeles, USA.

By selling its Brand New Day and Central Health MA plans, Bright Health, which would no longer be in the insurance business following the sale, intends to focus on its consumer care products, CFO Cathy Smith said.

The insurer plans to exit the state this year after consistently recording medical loss ratios over 100%, executives said on an earnings call.

Sarepta’s biomarker-based data “do not provide unambiguous evidence” of the therapy’s likely benefit for Duchenne muscular dystrophy patients, according to the regulatory agency.

The agreement is expected to increase access to next-generation sequencing for patients in more than 30 countries.

Analysts said the test is likely to meet the bar for FDA approval, but its flaws in detecting early-stage cancer weaken its chances against Exact Sciences’ stool-based test, Cologuard.

El cambio climático y el consiguiente calentamiento global amenazan con afectar a la distribución de especies vegetales. Concretamente en la región Mediterránea, donde las temperaturas altas coinciden con un periodo seco, los modelos climáticos predicen una reducci …